Deep Dive/ Market Access/ Views & Analysis/ Views and analysis Rethinking access barriers to innovation mike.hammerton@pharmaphorum.com ATMP, Deep Dive, Deep Dive: Market Access, Executive Insight, HTA, market access 0 Comment Market access issues don’t stop once a product has passed HTA – and this is especially true for Share X Rethinking access barriers to innovation https://pharmaphorum.com/views-analysis-market-access/rethinking-access-barriers-to-innovation/
Market Access/ Views & Analysis/ Views and analysis 2021 market access prospects for Germany Leela Barham AMNOG, ATMP, EU market access, Germany 0 Comment The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – Share X 2021 market access prospects for Germany https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-germany/
ATMP, Deep Dive, Deep Dive: Market Access, Executive Insight, HTA, market access
0 Comment
